| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC39 |
| UNII: | DB1041CXDG |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tubulin inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Amyloidosis, Familial | 2 | D028226 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298209 |
| FDA SRS | DB1041CXDG |
CONTENTS